Company BioSig Technologies, Inc.
Equities
BSGM
US09073N3008
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | +2.83% | +15.20% | -61.68% |
May. 20 | BioSig Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 03 | BioSig Technologies, Inc. Announces Board Appointments | CI |
Business Summary
Number of employees: 4
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BioSig
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -93.71% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -93.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | Feb. 26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 09-02-23 |
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | Feb. 26 |
Steven Abelman
BRD | Director/Board Member | - | May. 02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,198,174 | 8,713,324 ( 77.81 %) | 0 | 77.81 % |
Stock B | 0 | 105 | 0 | 0 |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.68% | 19.82M | |
+11.06% | 227B | |
+15.28% | 198B | |
+18.06% | 142B | |
+31.48% | 111B | |
+1.56% | 64.16B | |
+18.19% | 54.1B | |
+5.12% | 51.41B | |
+10.79% | 45.32B | |
+5.39% | 37.32B |
- Stock Market
- Equities
- BSGM Stock
- Company BioSig Technologies, Inc.